Ayr Strategies (AYRSF) Stock Price, News & Analysis

Company Overview

Ayr Strategies Inc. is a Canadian cannabis company engaged in licensed retail, cultivation and processing activities under the federal Cannabis Act. Traded on the OTC Marketplace as AYRSF, the company holds provincial permits to operate adult-use retail outlets and maintains federal licences for the production and processing of cannabis products.

Ayr Strategies employs an integrated approach, combining a growing network of brick-and-mortar retail stores with in-house cultivation and processing facilities. Its retail locations offer a curated assortment of dried flower, pre-rolled products, edibles and accessories, while its production capabilities are structured to ensure consistent supply, quality control and product innovation across its network.

The company’s retail footprint spans multiple Canadian provinces, including Ontario, Quebec and the Prairie markets, where it emphasizes customer education, regulatory compliance and community engagement. Headquartered in Vancouver, Ayr Strategies is overseen by an executive team with experience in retail operations, regulated product distribution and cannabis industry governance.

Key Stats

• Today's Range: $21.26 to $21.26
• 50-Day Range: $21.26 to $21.26
• 52-Week Range: $3.44 to $22.77
• Volume: N/A
• Average Volume: 38,816 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AYRSF Stock Analysis - Frequently Asked Questions

How have AYRSF shares performed this year?

Ayr Strategies' stock was trading at $21.26 at the beginning of 2025. Since then, AYRSF stock has increased by 0.0% and is now trading at $21.26.

How do I buy shares of Ayr Strategies?

Shares of AYRSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:AYRSF
• CIK: N/A
• Web: www.ayr.inc
• Phone: 949 574 3860
• Fax: N/A
• Employees: 2,380
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A